Brief: Sab Biotherapeutics Announces Exclusive Manufacturing Partnership With Emergent Biosolutions

SAB Biotherapeutics

27/10/2022 14:36

Oct 27 (Reuters) - Emergent BioSolutions Inc  EBS.N :
    * SAB BIOTHERAPEUTICS ANNOUNCES EXCLUSIVE MANUFACTURING
PARTNERSHIP WITH EMERGENT BIOSOLUTIONS
    * SAB BIOTHERAPEUTICS - EMERGENT WILL PROVIDE CONTRACT
DEVELOPMENT
AND MANUFACTURING SERVICES TO PRODUCE SAB'S FULLY-HUMAN
POLYCLONAL ANTIBODY PRODUCTS
    * SAB BIOTHERAPEUTICS - UNDER TERMS OF AGREEMENT, EMERGENT
WILL
PROVIDE END-TO-END GOOD MANUFACTURING PRACTICE (CGMP)
MANUFACTURING SERVICES TO SAB
    * SAB BIOTHERAPEUTICS - AGREEMENT PROVIDES OPPORTUNITY FOR
EMERGENT TO UTILIZE CO'S NOVEL DIVERSITAB PLATFORM FOR FUTURE
DEVELOPMENT OF UNDISCLOSED PROGRAMS
    * SAB BIOTHERAPEUTICS INC - FINANCIAL DETAILS OF AGREEMENT
WERE
NOT DISCLOSED

Source text for Eikon:  ID:nGNXbVtny4 
Further company coverage:  EBS.N 
 ((Reuters.Briefs@thomsonreuters.com;))